NEW YORK, July 14 (Reuters) - U.S. stocks rose on Monday
with the Dow Jones industrial average hitting a new intraday
high, lifted by better than expected earnings from Citigroup and
more deals in the healthcare space.

Boosting investors' confidence that the market is still
attractive to invest, Shire Plc, which sells drugs for rare
diseases, succumbed to an increased 31 billion pound ($53
billion) takeover offer from Abbvie Inc on Monday.

Generic drugmaker Mylan Inc said it would buy Abbott
Laboratories' specialty and branded generics business
outside the United States in an all-stock transaction valued at
about $5.3 billion. Mylan shares advanced 2.2 percent to $51.30
while Abbott shares rose 0.8 percent to $41.62.

Citigroup Inc shares rose 3.2 percent to $48.49 as one
of the top boosts to the S&P 500 after it posted second-quarter
earnings and agreed to pay $7 billion to settle a U.S.
government investigation into mortgage-backed securities. The
S&P financial index gained 0.6 percent.
Continuación...